On January 14, 2021 Ichnos Sciences Inc., a fully integrated, global biotechnology company developing potentially transformative biologic therapies that harness the immune system to treat cancer, reported that Alessandro Riva, M.D., Chief Executive Officer, will be presenting today at the virtual 39th Annual J.P. Morgan Healthcare Conference at 3:45 p.m. EST (Press release, Ichnos Sciences, JAN 14, 2021, View Source [SID1234574024]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live audio direct link to the virtual session, along with the slide deck, will be available at the following location (link). An archived replay of the presentation will be available (link) for 30 days following the event. These links will also be available on the Ichnos Sciences website.